Caring for animals matters
Together with other leading pharmaceutical companies Boehringer Ingelheim Animal Health engages in Vac2Vac, a joint EU research project which aims at improving animal welfare in vaccine quality control. Industrial and academic partners working together in the Vac2Vac initiative collaborate to research and develop innovative cell-based and other assay methods that can make in vivo
methods for routine batch quality, safety and efficacy testing of vaccines obsolete.
More information: IMI Press release 14 June 2016